Which one is more effective, Hetrombopag or Eltrombopag?
Heltrombopag, as a new generation anti-tumor drug of eltrombopag, has a faster onset of action and shows higher efficiency than eltrombopag. According to the clinical study results in the reference article, Hetrombopag has excellent performance in the treatment of R/R ITP (refractory immune thrombocytopenia). It can effectively increase platelet count, reduce bleeding events, and maintain a good quality of life.
Other applications: In addition to treating ITP, Hetrombopag combined with cyclosporineA also shows good efficacy in the treatment of children with non-severe aplastic anemia (NSAA), with a high overall response rate.

Eltrombopag increases platelet count by stimulating megakaryocyte proliferation and differentiation, which has the effects of increasing platelet count, improving hemostasis, and shortening coagulation time. Eltrombopag is not only suitable for the treatment of ITP, but is also commonly used in the treatment of chronic hepatitis B with thrombocytopenia (HBV-TP) and other diseases, and has shown good efficacy in immune thrombocytopenia. In some clinical studies, eltrombopag has shown high efficacy and complete response rates in the treatment of thrombocytopenia.
It can be seen from the above comparison that both heltrombopag and eltrombopag have good efficacy in increasing platelet count and improving hemostatic function. However, as a new generation drug, Hetrombopag has shown higher efficiency and excellent efficacy in terms of onset time and treatment of R/R ITP. At the same time, Hetrombopag also has good application prospects in the treatment of non-severe aplastic anemia in children.
The evaluation of drug efficacy needs to be comprehensively considered based on the patient's specific situation, disease type, severity, individual differences and other factors. Therefore, when choosing to use heltrombopag or eltrombopag, decisions should be made based on the doctor's advice and guidance, and the patient's condition changes and adverse reactions should be paid close attention to during the treatment process to ensure that the medication is safe and effective.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)